Business Context and Reporting Period
Company: Grupo Supervielle S.A. (Supervielle Group S.A.)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: August 25, 2017
Context: The filing announces the commencement of a global follow-on equity offering of Class B shares. The offering comprises an International Offering (registered with the SEC) and a concurrent Argentine Offering. The Company is an Argentine financial group.
Key Financial Metrics
The filing text does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on the structure and terms of the equity offering.
Material Changes and Offering Details
- Share Offering Volume:
- Company Offering: 70,000,000 Class B shares.
- Selling Shareholder Offering: 33,000,000 Class B shares (offered by Julio Patricio Supervielle, the controlling shareholder).
- Over-Allotment Option: International underwriters have an option to purchase up to 15,450,000 additional Class B shares, subject to adjustments for shares subscribed by existing shareholders exercising preemptive rights.
- ADS Structure: Each American Depositary Share (ADS) represents five Class B shares.
- Preemptive Rights: The Selling Shareholder has assigned its preemptive rights to subscribe up to 37,242,932 Class B shares to Banco Supervielle S.A. as subscription agent.
- Underwriters:
- Global Coordinator and Joint Bookrunner: BofA Merrill Lynch.
- Joint Bookrunners: Itaú BBA and J.P. Morgan.
- Local Placement Agents: AR Partners and Banco Supervielle.
Guidance, Outlook, and Risks
Timeline: The Global Offering is expected to price on or about September 12, 2017.
Regulatory Status: The International Offering is registered on Form F-3 and declared effective by the SEC. The Argentine Offering is authorized by the Comisión Nacional de Valores (CNV) under Resolution No. 18,856.
Risks and Contingencies:
- The filing includes forward-looking statements regarding the offering which may differ materially from actual events.
- No assurance is given that the equity offering will be consummated or regarding the ultimate terms of the transaction.
- Investors are directed to review "Risk Factors" in the preliminary prospectus supplement and the 2016 Form 20-F for detailed risks.
Investor Verification Checklist
- Verify the final pricing and total number of shares sold in the Global Offering once the September 12, 2017 pricing date passes.
- Review the full prospectus supplement and Form F-3 for detailed use of proceeds and specific risk factors.
- Confirm the extent to which existing shareholders exercise their preemptive and accretion rights, as this affects the over-allotment option.
- Monitor the dilution impact on existing shareholders resulting from the 70,000,000 shares offered by the Company and the 33,000,000 shares offered by the Selling Shareholder.